Статья

Covid‑19 in Northern Italy: An integrative overview of factors possibly influencing the sharp increase of the outbreak (Review)

M. Goumenou, D. Sarigiannis, A. Tsatsakis, O. Anesti, A. Docea, D. Petrakis, D. Tsoukalas, R. Kostoff, V. Rakitskii, D. Spandidos, M. Aschner, D. Calina,
2021

Italy is currently one of the countries seriously affected by the COVID-19 pandemic. As per 10 April 2020, 147,577 people were found positive in a total of 906,864 tests performed and 18,849 people lost their lives. Among all cases, 70.2% of positive, and 79.4% of deaths occurred in the provinces of Northern Italy (Lombardi, Emilia Romagna, Veneto and Piemonte), where the outbreak first started. Originally, it was considered that the high number of positive cases and deaths in Italy resulted from COVID-19 initially coming to Italy from China, its presumed country of origin. However, an analysis of the factors that played a role in the extent of this outbreak is needed. Evaluating which factors could be specific for a country and which might contribute the most is nevertheless complex, with accompanying high uncertainty. The purpose of this work is to discuss some of the possible contributing factors and their possible role in the relatively high infection and death rates in Northern Italy compared to other areas and countries. © 2020 Spandidos Publications. All rights reserved.

Цитирование

Похожие публикации

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • M. Goumenou
    Center of Toxicology Science and Research, Medical School, University of Crete, Heraklion, 71003, Greece
  • D. Sarigiannis
    HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Aristotle University of Thessaloniki, Thessaloniki, 57001, Greece
  • A. Tsatsakis
    School for Advanced Studies IUSS, Science, Technology and Society Department, Pavia, I-25100, Italy
  • O. Anesti
    I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, 119146, Russian Federation
  • A. Docea
    Department of Toxicology, University of Medicine and Pharmacy of Craiova, Craiova, 200349, Romania
  • D. Petrakis
    Metabolomic Medicine, Health Clinics for Autoimmune and Chronic Diseases, Athens, 10674, Greece
  • D. Tsoukalas
    Research Affiliate, School of Public Policy, Georgia Institute of Technology, Gainesville, VA 20155, United States
  • R. Kostoff
    Federal Scientific Center of Hygiene, F.F. Erisman, Moscow, 141014, Russian Federation
  • V. Rakitskii
    Laboratory of Clinical Virology, Medical School, University of Crete, Heraklion, 71003, Greece
  • D. Spandidos
    Department of Molecular Pharmacology, Albert Einstein College of Medicine, New York, NY 10461, United States
  • M. Aschner
    Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, Craiova, 200349, Romania
  • D. Calina
Название журнала
  • Molecular Medicine Reports
Том
  • 22
Выпуск
  • 1
Страницы
  • 20-32
Ключевые слова
  • age distribution; attitude to illness; clinical evaluation; comorbidity; comparative study; coronavirus disease 2019; diabetes mellitus; environmental factor; epidemic; family; genetic polymorphism; genetic susceptibility; habit; health care; health care organization; health status; human; hypertension; infection rate; Italy; malignant neoplasm; molecular evolution; mortality rate; obesity; physical activity; population density; population health; Review; Severe acute respiratory syndrome coronavirus 2; smoking; social life; virus transmission; epidemiology; isolation and purification; pandemic; risk factor; COVID-19; Disease Outbreaks; Humans; Italy; Pandemics; Risk Factors; SARS-CoV-2
Издатель
  • Spandidos Publications
Тип документа
  • Review
Тип лицензии Creative Commons
  • CC
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus